Introducing a third article type – the Protocol Extension

2016 is an important year for Nature Protocols as in the summer we will be celebrating our 10 year anniversary. Both in response to the success of some of our earlier protocols and reflecting the enormous improvements in the methods available to researchers over the past ten years, this month we are launching a new article type, the Protocol Extension.

Our first Protocol Extension is, as the name implies, still in the traditional protocol format. The method described in this article is based on an earlier version of the technique, for which we published a protocol back in 2006 from a different research group. This protocol is widely used by researchers and various changes to methodology have been made over recent years. Several of these adaptations are described in the new Protocol Extension article. Unlike Protocol Update articles, which should be used in place of the protocol they update, Protocol Extension articles provide a substantial modification or additional applications. They complement, rather than replace the earlier protocol, and may be authored by the same, or a different group of researchers. However, they also have some similarities to Protocol Updates, in that the Protocol Extension articles have headers to make their article type clear, they are always at the start of an issue, and there is a statement in the abstract to make it clear the article modifies or offers additional applications to one or more existing protocols.

As method development is an iterative process it is not always clear what constitutes an extension to a protocol. Very few new methods are developed that do not build on an earlier method, thus most of our protocols could be viewed as extending existing methods to a certain extent. In view of this we have decided to reserve this new article type for those articles where a new protocol is clearly warranted, and there is a clear reason to link the new article to an earlier protocol, for example, where sections of the procedure are the same.

As always, if you have any comments and suggestions, we would very much like to hear your views.

Stem cells in Singapore

At the start of last month I headed to Singapore for the ISSCR Regional Forum “Global Controls in Stem Cells”. I had a great time and found the meeting a big improvement on last year’s Florence meeting, due to the increase in networking opportunities.

There was a lot of epigenetics at the meeting – as you’d expect given the topic focus. Several people showed the classic Waddington depiction of the epigenetic landscape and explained the need to define where in the landscape the various cell types present during human development lie, plus the different varieties of artificially engineered stem cells. It was fascinating to hear about the various different approaches being taken to address this question.

I don’t have the space to discuss every talk, so here is a brief summary of the sessions and some of the talks.

The first keynote of the meeting was from Rudolf Jaenisch. He started by talking about naïve versus primed embryonic stem cells (ESCs) and whether there is a single human naïve state. He then moved on to talk about finding disease-relevant phenotypes, for example using patient-derived induced pluripotent stem cells (iPSCs). He particularly focused on the need for an appropriate control, he favours an isogenic control to control for genetic background.

The first session was focused on reprogramming, with various researchers talking about their attempts to improve reprogramming and to dissect reprogramming pathways. Jonathan Loh talked about the miniaturised reprogramming system using 384 well plates his group has developed to aid this process. Hongkui Deng finished the morning talks with a fantastic talk about reprogramming human fibroblasts to hepatocytes with drug metabolic function. Up until now reprogrammed hepatocytes have lacked this function, which is so important if hepatocytes derived in this way are going to be used for drug screening.

After lunch there was a session on chromatin dynamics. Bing Ren focused on the functional analysis of transcriptional enhancers and developing a new way to look at gene regulation from a 3D point of view. Sung Hee Baek talked about chromatin modifiers in epigenetic control of cancer and stem cells. Ken Zaret talked about the initiation of cell reprogramming, specifically his efforts to identify “Pioneer factors”, these bind to target genes that will turn on later. The final talk in this session was from Ralf Huss, about using stem cells as drug delivery tools in cancer therapy, due to their propensity to home in on the tumour.

The first session of day 2 was devoted to the developmental biology of pluripotency. Ron McKay, one of the conference organisers, spoke on the need to understand the functional identity of human genomes. Many early lineage cell types can be grown, and the human ESC are all quite different. This variation needs to be understood. Sara-Jane Dunn talked about her computational work modelling pluripotency, an alternative approach to investigating this biological phenomena.

The first session after lunch was on Telomere and RNA biology. V. Narry Kim spoke first. The main focus of her lab is miRNA regulation, but in this talk she talked about RNA-binding proteins in ESC. Next up was Didier Trono who talked about how transposable elements and their epigenetic control mechanisms are key regulators of transcriptional networks in PSCs. Yue Wan talked about the importance of RNA structure in determining RNA function, and the need to learn more about RNA structure. Toshio Suda talked about the aging of hematopoietic stem cells. Stem cells are long lived, and they do change as they age. He talked about the different characteristics of “elderly” stem cells.

The first session of Friday morning was focused to Functional Genomics. Huck Hui Ng gave the first talk, on his work investigating the systems biology of stem cells. Andras Nagy talked about his groups attempts to produce a stable pluripotent cell quite different from ESCs. Frank Buchholz talked about using RNA screens to find modulators and regulators of the pluripotent state.

After lunch there was a Cancer session, covering a wide variety of aspects. Richard Young started the session with a talk about the roles of transcriptional super-enhancers in cell identity and cancer. Zsuzsanna Izavak talked about her recent Nature paper on transcription driven by primate-specific endogenous retrovirus HERVH in naïve stem cells. The HERV driven network partially explains differences in mouse and human stem cells. The significant differences between mouse and human stem cells were mentioned by several of the speakers throughout the conference. Jesse Smith talked about gene transcription inhibitors as potential cancer therapeutics. The rationale being that cancer can be viewed as a disease of de-differentiation, i.e. dysregulated gene transcription.

Yukiko Gotoh talked about regulation of neural stem / progenitor cell fate in the embryonic and adult mouse brain. The basic premise of her work is that embryonic neural stem cells build a brain, whilst adult neural stem cells have a very different role, e.g. in learning and memory.

Janet Rossant gave the closing keynote lecture. She talked about cells in early embryo development and studies looking at when developmental potential is lost, comparing the mouse and human embryo. She also emphasised the differences between mouse and human early embryo development, and the importance of remembering this when studying stem cells.

I very much enjoyed my time in Singapore – it really is a beautiful city. I attended the night safari on the conference networking trip, which was great fun and a really unique experience. I even managed to secure a gift for my children left at home – a lego “Mr Stem Cell” so I can introduce them to the delights of stem cells at an early age!

Decoding neural circuit structure and function workshop

The last couple of months have been busy for the Nature Protocols editors, with Mel and I both travelling a fair amount. The end of September saw me heading off to Istanbul, Turkey for the EMBO workshop on “Decoding neural circuit structure and function”. I had been thinking a little warmth at the end of September would be a welcome change, but ironically I think it was actually warmer in London! And we didn’t really need all the rain to encourage us to attend sessions, given the excellent line up.

I don’t have the space to discuss all the talks at great length, and it was also encouraging to see so much unpublished data being presented, which I must not share. But here are my highlights.

The first talk of the meeting was by Juergen Knoblich, and it was great to hear about his current projects, using Drosophila genetics to understand cell cycle exit and quiescence plus the contribution of changing the balance of asymmetric versus symmetric divisions in development of various disorders. It was also good to hear that his group are doing more work on the brain organoids, whose creation has already been explained in their group’s recent Nature Protocols article. I was intrigued that a member of the audience asked about the ethical implications of such organoids – it was a question I asked myself whilst editing our article.

I enjoyed learning about behavioural assays using the larval zebrafish from Florian Engert. It was amazing to see what such tiny organisms are capable of. Scott Waddell’s talk was focused to resolving how an animal decides to do the most appropriate thing at a particular moment, using Drosophila as his model system. This question came up as the main research question being addressed in several speaker’s talks.

Another fascinating talk was by Leslie Vosshall on “Sensory cues driving host-seeking behavior in the dengue vector mosquito Aedes aegypti”. Leslie’s groups’ research should help address whether there is any truth in the various old wives tales concerning whether particular factors increase a person’s attractiveness to mosquitos. I spoke to some other researchers about Leslie’s talk and they are confident Leslie will be able to improve the repertoire of molecular biology research tools available for the study of Aedes aegypti. So, it is worth keeping an eye on what Leslie is up to.

The final talk of the conference was by Gero Miesenböck. I very much enjoyed the pictures of the T-maze apparatus his group uses to perform mass behavioural assays in Drosophila.

In addition to all the fabulous talks there were stimulating poster sessions. I particularly liked the poster by Deniz Atasoy from Medipol University, Istanbul, on a Genetically encoded synaptic marker for electron microscopy (GESEM) that he developed. This poster was awarded the Nature Protocols poster prize, going to the poster with the best protocol behind it. Special mention should also go to Xuefan Gao from the Max Planck Institute for Developmental Biology in Tubingen, whose poster on AVEXIS, a protein-protein interaction screen assay, was also very methodological in slant.

Do let us know if you are organising a conference and would like to have a Nature Protocols poster prize as we are always looking out for opportunities to sponsor such prizes.

We also enjoyed conference dinners at Boğaziçi Üniversitesi and on a boat on the Bosphorus – so it wasn’t all work! The conference organisers, Arzu Celik, Nilay Yapici and Hernan Lopez-Schier, deserve a special thank you for being so welcoming and organising such a good program. Istanbul is a beautiful city and well worth a visit.

Top 100 papers of all time

I recently gave a talk in Singapore about publishing in Nature Protocols. When I give these talks, one of the things I explain is why Nature Publishing Group is interested in publishing methodological information. For that specific talk I had great new supporting document – an article in the previous weeks Nature about the “top 100 papers”. Of course, my top 100 papers is going to be very different from yours, but the top 100 for the purposes of this article was defined as the most cited papers of all time in the Science Citation Index, owned by Thomson Reuters.

cover_nature

When I saw the cover of Nature that week, and learnt of the news story, I knew what the most cited articles were going to be – methods papers. I knew about the high cites because when we first launched Nature Protocols we looked to see which methods papers were most cited, indicative, we believed, of people having reproduced the method and being in need of a protocol. We found such papers had amazingly high cites. An example of one of the highly cited papers serving as the inspiration for a protocol was the paper by Piotr Chomczynski and Nicoletta Sacchi on isolating RNA. We felt it was important that users of the assay understood how and why it worked, and published a protocol on the assay by the original inventors.

It will be fascinating to look in ten years’ time to see the methods being invented now that have taken off and revolutionised the way we do research. I very much hope our protocols will have helped facilitate their adoption in new labs around the world.

Introducing a new article type – the Protocol Update

Nature Protocols is coming to the end of its 7th volume, and after publishing only one type of article for the past seven years, this month sees the introduction of a brand new article type: the Protocol Update.

At first glance our first Protocol Update1 follows the same basic format as the hundreds of Protocols we’ve published so far.   However it is an acknowledgement that over time protocols are improved upon.  The major differences between Protocol Updates and Protocols are:

  • Protocol Updates have headers to say it is an update
  • Protocol Updates are always at the start of the issue
  • Protocol Updates  contain a statement at the start to make it clear it is an update of a protocol we published previously (back in 20062  in this first example).
  • Protocol Updates include a discussion of how this new version compares to the original, explaining the rationale for the improvements as well as making it clear which parts remain the same.

You may be wondering why we have introduced this new article type.  Whilst we have the functionality for authors and readers to comment on protocols, these comments are not peer reviewed and their presence at the end of a protocol means they can be missed by readers of the protocol.  For the particular protocol we have updated, the authors, referees and editors agreed that there were sufficient improvements to the procedure presented back in 2006 to justify publishing a new version.  The area covered – quality assurance for polychromatic flow cytometry – is basic but important to get right.  It is needed to support a diverse range of methods with many biological applications, and this importance has driven various improvements.  We decided we should acknowledge this and provide an updated protocol for its many users.  However as it is not a new protocol – the authors are the same, the applications the same, and even some of the text – we are not labelling it as a new protocol.  So you will see, if you compare the articles, that where there is new information, this is included, however where there is no change, but the information remains important for users of the protocol, it has been retained.

Given our large scope, and the many innovative new methods being developed, we don’t anticipate publishing many Protocol Update articles each year.  There is just too much exciting research going on and it is important to focus on covering these new protocols, plus those we have still not managed to cover in the past seven years.  The choice available to editors when commissioning new protocols can be overwhelming so we aim to continue to focus on commissioning topics we have not covered previously rather than revisiting what we have already published.  However, we felt we needed the option, occasionally, to update an area we’ve covered before.

If you have any comments and suggestions we are, as always, keen for feedback.

1Perfetto, S.P., Ambrozak, D., Nguyen, R., Chattopadhyay, P.K. and Roederer, M. Quality assurance for polychromatic flow cytometry using a suite of calibration beads.  Nat. Protoc.   7 2067–2079 (2012)

2 Perfetto, S.P., Ambrozak, D., Nguyen, R., Chattopadhyay, P. and Roederer, M. Quality assurance for polychromatic flow cytometry. Nat. Protoc. 1 1522-1530 (2006)

Nature Protocols and Impact Factors

When we first launched "Nature Protocols ":https://www.nature.com/nprot I was keen to get our protocols indexed by all the big players. Whilst there was going to be a marketing campaign with ads in Nature and banner ads all over nature.com I knew we’d only get real users when people did their literature search and one of our protocols came top of the list. We wanted to be something researchers needed and found useful. However, alongside getting listed in the ISI Web of Knowledge came the news we’d also be eligible for an Impact Factor. It was clearly something scientists cared about. A lot of our early correspondence was about what our Impact Factor was. We had to be very apologetic and explain that we didn’t have one – first we’d need to publish some protocols, and then wait to see if they were cited. Personally I was relieved we didn’t have one because I wasn’t sure what an impact factor would mean for us, even if we did have one.

The Impact Factor comes into its own as a comparative factor. That’s why my colleagues upstairs at Nature are delighted with theirs, as at 36.101 it puts them ahead of their competitors. And also why journals with impact factors of 1 or 2 can also be delighted, as such an Impact Factor can be the highest in their specialist field. But when I looked into Impact Factors I realised that no protocols publications had them, so as a comparative factor, our impact factor would be rather meaningless. When and why would people cite protocols? We certainly wouldn’t be cited because we presented exciting new data and reported a major advance in scientific knowledge. I hoped that we’d be cited if we were used – and so lots of use would lead to a high impact factor. We’d obviously only get cited if the experiment worked, and so a higher impact factor would indicate good, reliable protocols. But, maybe we wouldn’t get cited, as citing the source of your protocol didn’t seem to be the ‘done thing’ at the time.

Five years down the line – with a 2 year ISI Impact Factor of 8.362 – I am pleased to report that we are being cited. We have an Immediacy Index of 1.547 and "Article Influence Score ":https://en.wikipedia.org/wiki/Article_influence_score of 3.799. We’re all rather pleased, as we know our Impact Factor matters to some of our authors. We’re also curious – which articles have people been citing? Are they the methods people have been using? Have they been getting good results? How do these articles correlate with the articles that are most downloaded from our site?

Our most highly cited article according to ISI is Locating proteins in the cell using TargetP, SignalP and related tools by Emanuelsson et al. This is different from the most highly cited article according to Scopus – "Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources ":https://dx.doi.org/10.1038/nprot.2008.211 – by Huang et al., although this comes in at second place. At third we have "Analyzing real-time PCR data by the comparative C-T method ":https://dx.doi.org/10.1038/nprot.2008.73 by Schmittgen et al. And in fourth, "In-gel digestion for mass spectrometric characterization of proteins and proteomes ":https://dx.doi.org/10.1038/nprot.2006.468 by Shevchenko _et al. _and in fifth, Protein structure prediction on the Web: a case study using the Phyre server. Interestingly there are lots of bioinformatics protocols in this list.

Of course, our 2010 2 year Impact Factor is only based on articles published in 2008 and 2009, so only two of those protocols, those in second and third place, will have been included. And also, only the cites in 2010. I was – and remain – curious about our five year impact factor. Whilst methods are developing all the time, protocols do tend to have a long life. A tweak here and there (hopefully highlighted as a comment to the protocol), but we hope our more useful protocols will still be in use, and cited, 5 years on. I guess we’ll have to wait and see

Happy Birthday Nature Protocols – 5 today!

Five years ago today we launched Nature Protocols. It was the culmination of 6 months of hard work for the editorial team. Dot Clyde and myself had both started work at NPG at the start of January with a long list of things to sort out. First we had to decide on our scope, answering questions such as do physicists use protocols? Next we had to decide on a format. Although we had a rough guide from our colleagues on Nature Methods who had published some protocols, we had much more freedom. No page budgets and an online format. Dot had just left the lab, as had the rest of the editorial team we recruited (Bronwen, Alex, Andy, Baldo and Hannah), so there was much discussion of what scientists REALLY wanted to know about. Next there was peer reviewing – what would we ask the peer reviewers to do? Ideally we’d have liked them to repeat the procedure, but clearly that was not practical (although on occasion we have had peer reviewers do just that!) And then there was presentation – sorting out exactly how we would present all that information we gathered. Plus who was going to copy edit it all. Then of course, last, but most certainly not least, who would we invite to write? And would they agree to write for this new type of publication?

Thankfully many of the authors we approached were as enthusiastic about the concept of Nature Protocols as we were. We quickly received plenty of manuscripts to send out to peer review (helped by the fact that the protocols were already written and much tried-and-tested in our authors labs). Many of the peer reviewers we approached were pleased to help, and on 12th May we put our first example protocols on our web page. It was great to finally have some actual content, alongside the information about what we were doing.

Then on June 30th 2006 we published our first batch of content – a whopping 87 Nature Protocols protocols. Over the following months we published many more so by 29th December we’d published 322. By January 2008 we had over 1000 protocols on our site, including almost 800 Nature Protocols protocols.

In addition, we’d also worked on our system for researchers to post protocols-in-progress onto the site. Then called the Protocols Network, this launched with 14 protocols, all contributed by authors of recent papers published in other Nature publications. Today that system is bigger and better than ever before, and was recently relaunched as the Protocol Exchange, including lots of added featured we didn’t quite get round to including in 2006.

So, 5 years on, where is Nature Protocols now? The editors are all a little older (here we all are back in 2006):

Copy (2) of S4200028.JPG

On the roof terrace in the summer of 2006. Back row, from left: Andy, Alex, Dot, Baldo. Front row, from left: Katharine, Hannah, Naomi (our first editorial assistant), Bronwen.

The feedback we’ve had from authors and users has been fantastic and largely positive, which is the best reward an editor can have. Our most cited article on Scopus – "Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources by Huang, Sherman and Lempicki ":https://dx.doi.org/10.1038/nprot.2008.211 – published in December 2008 has been cited 847 times. We’ve published old favourites, such as the single step method of RNA isolation by acid guanidinium thiocyanate-phenol-choroform by Piotr Chomczynski & Nicoletta Sacchi and the latest protocols published in Nature, such as "Kazutoshi Takahashi, Keisuke Okita, Masato Nakagawa & Shinya Yamanakas’ protocol for the induction of pluripotent stem cells from fibroblast cultures ":https://dx.doi.org/10.1038/nprot.2007.418. We’ve followed dramatic progress in certain fields – for example, the new protocols available using next generation sequencing have revolutionised research progress. It’s now possible to rapidly sequence single cells, as demonstrated by Fuchou Tang, Catalin Barbacioru, Ellen Nordman, Bin Li, Nanlan Xu, Vladimir I Bashkirov, Kaiqin Lao & M Azim Surani who used RNA-Seq analysis to capture the transcriptome landscape of a single cell. We continue to enjoy following the progress of stem cell research, which, as well as making dramatic progress actually generating stem cells, has produced improved protocols for researchers in other areas, such as the ability to generate gene knockout rats, described by Chang Tong, Guanyi Huang, Charles Ashton, Ping Li & Qi-Long Ying.

And the future? Well, I’ve taken a step back now and so that’s a question for our current Chief Editor, Chris Surridge, but I am sure we will continue to concentrate on our core aim back from 2006 of “publishing the protocols being used to answer outstanding biological and biomedical science research questions, including methods grounded in physics and chemistry that have a practical application to the study of biological problems”. All that’s left for me to do now is give a final thanks to all who have contributed to the success of Nature Protocols so far and say, heres to the next 5 years!

Focusing on stem cells

Since Nature Protocols launched we’ve been having a shall-we-shan’t-we discussion about the relative merits of article series. On one hand they seem such a great idea – bringing together lots of protocols in a specific area to make life easier for researchers in that area. On the other hand we worry they’ll alienate researchers working on other things – why do the mass spectrometrists get special treatment and not us? And how do you decide what to include on such a page – anything vaguely connected or just the hard core of a particular topic? Then finally, as an Editor I just find myself wondering why I am making more work for myself…

But back in 2009 we took the plunge and launched our Stem Cell Series page. At the time stem cells were all the rage – if you watched the TV news at night you’d think all diseases were on the verge of being cured by these fantastic new cells. Unless you lived in the US, where they were not viewed so kindly by some.

Recently the page has slipped a bit in priorities – launching the Protocol Exchange was quite a job. But we feel it’s now time to revitalise it. Stem cells remain a hot research topic, and the optimism about their potential remains. Each week more and more possible applications are being devised. I’m pleased to see that our recently published stem cell protocols are reflecting this increased variety. Currently featured, in addition to our typical protocols showing how to get your stem cells initially, or how to go from stem cells to your cells of choice, there are some intriguing ways to look at your stem cells. Some of these methods can be applied to cells other than stem cells so do check it out even if your favourite cell is not a stem cell.

The juries still out on whether series pages are a useful addition to our site. So, if you’ve not checked for a while, or if you’ve not looked at all, we do suggest you take a peek. And do let us know what you think – should we run series or not? And if so, what topics should we cover?